TB Alliance Case Study on Expanding Access to Life-Saving Tuberculosis Treatments Published by INSEAD
MBA students tackle one of global health’s toughest challenges – how to reduce drug rollout timelines to just one year
MBA students tackle one of global health’s toughest challenges – how to reduce drug rollout timelines to just one year
The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) is a valued member of TB Alliance’s Global TB Stakeholders, bringing decades of
Findings underscore critical role of product development partnerships in delivering both innovation and access GENEVA (April 24, 2026)—A new peer-reviewed
Country-led evidence and implementation support enabled faster adoption of shorter, more effective regimens worldwide SEOUL (April 13, 2026)—A new independent
TB Alliance warmly congratulates Bruce Carter, PhD, on his appointment as an Officer of the Order of the British Empire
Global health leader brings deep expertise in advancing children’s health, HIV, and global health equity NEW YORK (March 2, 2026)—TB
New collaboration aims to advance innovation for a neglected and stigmatizing disease affecting hundreds of thousands worldwide NEW YORK (January
Partnership will support the development of investigational drug telacebec for the treatment of tuberculosis, leprosy, and Buruli ulcer NEW YORK
New York, USA and Manila, Philippines — [Date] — TB Alliance and the Asian Development Bank (ADB) have announced a
For many children, and plenty of adults, swallowing tablets is hard. Ready-made syrups are often unavailable, poorly palatable, or impractical